PRKN and Parkinson disease: In addition, it is necessary to study the effect of Pink1 and Parkin activators on other features of the pathogenesis of neurons in PD in addition to protection against neurodegeneration, namely, the reduction of neuroinflammation and the normalization of energy status with the restoration of ATP production.